Stada receives takeover bids from Cinven & Advent International

The German drugmaker has reportedly received a € 3.5 billion bid from private equity group Cinven

Premium

BS B2B Bureau Bad Vilbel, Germany

Last Updated : Feb 14 2017 | 4:37 PM IST

Stada Arzneimittel AG, the German manufacturer of generic and OTC (over-the-counter) drugs, has confirmed that it has received two legally non-binding expressions of interest regarding a bid for the acquisition of up to 100 percent of the shares in the company.

One of the proposal was submitted by private equity group Cinven Partners LLP at an indicative takeover price of Euro 56.00 per Stada share – the cumulative value of which amounts to € 3.5 billion. Stada received the second proposal from Advent International Corporation.

“Both legally non-binding expressions of interest from Cinven Partners LLP and from Advent International Corporation, which the

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in